Latest News and Press Releases
Want to stay updated on the latest news?
-
SYDNEY, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces that due to the recent accelerated screening and enrolment in the XanaMIA phase 2b/3 Alzheimer’s disease (AD)...
-
Annovis will host corporate update webinar on January 28, 2026
-
Beacon Biosignals partners with Harmony Biosciences to quantitatively measure excessive daytime sleepiness in phase 3 clinical trial.
-
TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is...
-
PharmAla ships MDMA to Mt. Sinai Hospital and starts making patented novel MDMA-like drug, preparing for a phase 2 clinical trial into Social Anxiety.
-
TrialWire®, the industry’s fastest, intelligent patient recruitment engine proudly supported Endpoints News Clinical Trial Day 2025.
-
4D Path has announced a collaboration with AMD and Oracle to advance predictive oncology and accelerate clinical trials.
-
Avance Clinical has announced the launch of its new Diversity in STEM Scholarships, in Australia and North America.
-
TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is...
-
Dublin, Dec. 04, 2025 (GLOBE NEWSWIRE) -- The "Clinical Data Analytics Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.The Clinical Data Analytics...